Statement of Ownership (sc 13g)
September 30 2019 - 8:44AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)*
Cortexyme,
Inc.
(Name of Issuer)
Common Stock, par value $0.001
(Title of Class of Securities)
22053A 107
(CUSIP
Number)
September 30, 2019
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
*
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of
the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13G
CUSIP No. 22053A 107
|
|
|
|
|
|
|
1
|
|
Names of
Reporting Persons
Pierre R.
Lamond
|
2
|
|
Check the appropriate box if a member
of a Group (see instructions)
(a) ☐ (b) ☒
|
3
|
|
Sec Use Only
|
4
|
|
Citizenship or Place of
Organization
United States of America
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5
|
|
Sole Voting Power
1,924,020(1)
|
|
6
|
|
Shared Voting Power
962,510(2)
|
|
7
|
|
Sole Dispositive Power
1,924,020(1)
|
|
8
|
|
Shared Dispositive Power
962,510(2)
|
9
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,886,530
|
10
|
|
Check box if the aggregate amount in
row (9) excludes certain shares (See Instructions)
☐
|
11
|
|
Percent of class represented by amount
in row (9)
10.75%
|
12
|
|
Type of Reporting Person (See
Instructions)
IN
|
(1)
|
Includes: (i) 961,510 shares of common stock held of record by Pierre R. and Christine E. Lamond Trust 11-22-85 and (ii) 962,510 shares of common stock held of record by Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019. Mr. Pierre R. Lamond is the sole
trustee of both trusts.
|
Page 2 of 7
(2)
|
Consists of 962,510 shares of common stock held by Christine E. Lamond 2019 Annuity Trust A dated March 4,
2019 of which Ms. Christine E. Lamond, the spouse of Mr. Pierre R. Lamond is the sole trustee. Mr. Pierre R. Lamond is the spouse of Ms. Christine E. Lamond and may be deemed by the Securities and Exchange Commission under
Rule 13d-3 of the Securities Exchange Act of 1934, as amended, to have shared voting power to dispose of the shares held directly or indirectly by Ms. Christine E. Lamond.
|
Page 3 of 7
Item 1.
|
(a) Name of Issuer:
|
Cortexyme, Inc.
(b) Address
of Issuers Principal Executive Offices:
269 East Grand Avenue, South San Francisco, CA 94080
Item 2.
|
(a) Name of Person Filing:
|
Pierre R. Lamond
(b) Address
of Principal Business Office or, if None, Residence:
269 East Grand Avenue, South San Francisco, CA 94080
(c) Citizenship:
United
States of America
(d) Title of Class of Securities:
Common Stock, par value $0.001
(e) CUSIP No.:
22053A 107
Item 3.
|
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
|
|
|
|
(a)
|
|
☐
|
|
Broker or dealer registered under Section 15 of the Act (15 U.S.C.78o);
|
|
|
|
(b)
|
|
☐
|
|
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C.78c);
|
|
|
|
(c)
|
|
☐
|
|
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C.78c);
|
|
|
|
(d)
|
|
☐
|
|
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
|
|
|
(e)
|
|
☐
|
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
|
|
(f)
|
|
☐
|
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
(g)
|
|
☐
|
|
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
|
|
(h)
|
|
☐
|
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
(i)
|
|
☐
|
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15
U.S.C.80a-3);
|
Page 4 of 7
|
|
|
|
|
(j)
|
|
☐
|
|
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
|
|
|
|
(k)
|
|
☐
|
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with
§240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not Applicable
|
(a)
|
Amount Beneficially Owned:
|
2,886,530 shares of common stock. This amount includes: (i) 961,510 shares of common stock held of record by Pierre R. and Christine E. Lamond
Trust 11-22-85, (ii) 962,510 shares of common stock held of record by Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and (iii) 962,510 shares of common
stock held of record by Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019. Mr. Pierre R. Lamond is the trustee of Pierre R. and Christine E. Lamond Trust
11-22-85 and Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and holds sole voting and dispositive power with respect to the shares held of record by
both trusts. Mr. Pierre R. Lamond is the spouse of Ms. Christine E. Lamond and may be deemed by the Securities and Exchange Commission under Rule 13d-3 of the Securities Exchange Act of 1934, as
amended, to have shared voting power to dispose of the shares held directly or indirectly by Ms. Christine E. Lamond.
The common stock represents approximately 10.75% of the Issuers common stock, based on 26,841,149 issued and outstanding shares of common
stock of the Issuer as of August 9, 2019, as reported in the Issuers Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on August 9, 2019.
(c)
|
Number of shares as to which the person has:
|
|
|
|
|
|
(i)
|
|
Sole power to vote or to direct the vote:
|
|
1,924,020
|
|
|
|
(ii)
|
|
Shared power to vote or to direct the vote:
|
|
962,510
|
|
|
|
(iii)
|
|
Sole power to dispose or to direct the disposition of:
|
|
1,924,020
|
|
|
|
(iv)
|
|
Shared power to dispose or to direct the disposition of:
|
|
962,510
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
Not applicable.
Item 6.
|
Ownership of more than Five Percent on Behalf of Another Person.
|
Not applicable.
Item 7.
|
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the
Parent Holding Company or Control Person.
|
Not applicable.
Item 8.
|
Identification and Classification of Members of the Group.
|
Page 5 of 7
Not applicable.
Item 9.
|
Notice of Dissolution of Group.
|
Not applicable.
(a) Not applicable.
(b) Not
applicable
Page 6 of 7
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
PIERRE R. LAMOND
|
|
|
|
|
September 30, 2019
|
|
|
Date
|
|
|
|
|
/s/ Pierre R. Lamond
|
|
|
Signature
|
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Apr 2024 to May 2024
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From May 2023 to May 2024